TY - JOUR
T1 - Management of blood transfusion services in low-resource countries
AU - the ISBT Convalescent plasma working group
AU - Patidar, Gopal K.
AU - Thachil, Jecko
AU - Dhiman, Yashaswi
AU - Oreh, Adaeze
AU - Vrielink, Hans
AU - van den Berg, Karin
AU - Grubovic Rastvorceva, Rada M.
AU - So-Osman, Cynthia
AU - Al-Riyami, Arwa Z.
N1 - Publisher Copyright:
© 2022 International Society of Blood Transfusion.
PY - 2022
Y1 - 2022
N2 - Background and Objectives: Enabling universal access to safe blood components should be a key component of every country's national healthcare strategy. This study aimed to assess the current status of infrastructure and resources of blood transfusion services (BTS) in low- and middle-income countries. Materials and Methods: A cross-sectional survey was designed to gather information on blood donations, components, redistribution, testing resources and quality management systems (QMSs). The survey was distributed to the International Society of Blood Transfusion members between October 2021 and November 2021. Results: A total of 54 respondents from 20 countries responded to the survey. This included hospital-based BTS/blood centres (46%), national blood centres (11%)and national and regional blood services (11%). Voluntary non-remunerated, replacement and paid donors accounted for 94.2%, 84.6% and 21.1% of donations, respectively. Apheresis donation was available in 59.6% of institutions. National/regional criteria for redistribution of blood components were reported by 75.9% of respondents. Blood components incurred payment charges in 81.5% of respondents' institutions, and payments were borne by patients in 50% of them. Testing methods, such as manual (83%), semi-automated (68%) or fully automated (36.2%), were used either alone or in combination. QMSs were reported in 17 institutions, while accreditation and haemovigilance were reported in 12 and 8 countries, respectively. Conclusion: QMS was implemented in most of the countries despite the common use of paid donations and the lack of advanced testing. Efforts to overcome persistent challenges and wider implementation of patient blood management programmes are required.
AB - Background and Objectives: Enabling universal access to safe blood components should be a key component of every country's national healthcare strategy. This study aimed to assess the current status of infrastructure and resources of blood transfusion services (BTS) in low- and middle-income countries. Materials and Methods: A cross-sectional survey was designed to gather information on blood donations, components, redistribution, testing resources and quality management systems (QMSs). The survey was distributed to the International Society of Blood Transfusion members between October 2021 and November 2021. Results: A total of 54 respondents from 20 countries responded to the survey. This included hospital-based BTS/blood centres (46%), national blood centres (11%)and national and regional blood services (11%). Voluntary non-remunerated, replacement and paid donors accounted for 94.2%, 84.6% and 21.1% of donations, respectively. Apheresis donation was available in 59.6% of institutions. National/regional criteria for redistribution of blood components were reported by 75.9% of respondents. Blood components incurred payment charges in 81.5% of respondents' institutions, and payments were borne by patients in 50% of them. Testing methods, such as manual (83%), semi-automated (68%) or fully automated (36.2%), were used either alone or in combination. QMSs were reported in 17 institutions, while accreditation and haemovigilance were reported in 12 and 8 countries, respectively. Conclusion: QMS was implemented in most of the countries despite the common use of paid donations and the lack of advanced testing. Efforts to overcome persistent challenges and wider implementation of patient blood management programmes are required.
KW - accreditation
KW - blood transfusion services
KW - low- and middle-income countries
KW - quality management systems
UR - http://www.scopus.com/inward/record.url?scp=85141736808&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85141736808&partnerID=8YFLogxK
U2 - 10.1111/vox.13373
DO - 10.1111/vox.13373
M3 - Article
C2 - 36349461
AN - SCOPUS:85141736808
SN - 0042-9007
JO - Vox Sanguinis
JF - Vox Sanguinis
ER -